Allianz
UTHR icon

Allianz’s United Therapeutics UTHR Stock Holding History

Allianz’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$182K Buy
+335
New +$173K ﹤0.01% 391

Other funds holding UTHR

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Allianz's UTHR Position: Q3 2026 in Review

Allianz opened a new position in United Therapeutics (UTHR) in Q3 2026: 335 shares worth $182K. The stake represents ﹤0.01% of the portfolio and ranks #391 among its holdings.

673 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Allianz held 335 shares of United Therapeutics worth $182K as of Q3 2026.
  • United Therapeutics was a new Allianz position in Q3 2026.
  • United Therapeutics made up ﹤0.01% of Allianz's portfolio in Q3 2026, its #391 holding.
  • 673 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Allianz's 13F filing for Q3 2026, filed 12 Nov 2026.